Expression of Tau40 Induces Activation of Cultured Rat Microglial Cells

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Wang, Lu ^a,b   Jiang, Qian ^a   Chu, Jiang ^a   Lin, Li ^a   Li, Xiao Guang ^a   Chai, Gao Shang ^a   Wang, Qun ^a   Wang, Jian Zhi ^a   Tian, Qing ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLYCOGEN SYNTHASE KINASE 3; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MICROTUBULE ASSOCIATED PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN; TAU40 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; FRACTAL ANALYSIS; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; IN VITRO STUDY; MALE; MICROGLIA; MIGRATION; MOUSE; NERVE DEGENERATION; NONHUMAN; PHAGOCYTOSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; CALCIUM-BINDING PROTEINS; CELL MOVEMENT; CELLS, CULTURED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MEMBRANE PROTEINS; MICROFILAMENT PROTEINS; MICROGLIA; NITRIC OXIDE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHAGOCYTOSIS; PROTEIN PHOSPHATASE 2; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84885403183     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076057     Document Type: Article

References (91)

1. Vaughan DW, Peters A, (1974) Neuroglial cells in the cerebral cortex of rats from young adulthood to old age: an electron microscope study. J Neurocytol 3: 405-429.
2. Becher B, Prat A, Antel JP, (2000) Brain-immune connection: immuno-regulatory properties of CNS-resident cells. Glia 29: 293-304.
3. Aloisi F, (2001) Immune function of microglia. Glia 36: 165-179.
4. Koizumi S, Shigemoto-Mogami Y, Nasu-Tada K, Shinozaki Y, Ohsawa K, et al. (2007) UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature 446: 1091-1095.
5. McGeer PL, Rogers J, McGeer EG, (2006) Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years. J Alzheimers Dis 9: 271-276.
6. Kim YS, Joh TH, (2006) Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease. Exp Mol Med 38: 333-347.
7. Terry RD, Katzman R, (1983) Senile dementia of the Alzheimer type. Ann Neurol 14: 497-506.
8. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, et al. (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 83: 4913-4917.
9. Wyss-Coray T, (2006) Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 12: 1005-1015.
10. Meda L, Cassatella MA, Szendrei GI, Otvos LJ, Baron P, et al. (1995) Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 374: 647-650.
11. Braak H, Braak E, (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239-259.
12. Dickson DW, Crystal HA, Mattiace LA, Masur DM, Blau AD, et al. (1992) Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 13: 179-189.
13. Riley KP, Snowdon DA, Markesbery WR, (2002) Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. Ann Neurol 51: 567-577.
14. Grober E, Dickson D, Sliwinski MJ, Buschke H, Katz M, et al. (1999) Memory and mental status correlates of modified Braak staging. Neurobiol Aging 20: 573-579.
15. Bramblett GT, Goedert M, Jakes R, Merrick SE, Trojanowski JQ, et al. (1993) Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 10: 1089-1099.
16. Goedert M, Spillantini MG, Jakes R, Crowther RA, Vanmechelen E, et al. (1995) Molecular dissection of the paired helical filament. Neurobiol Aging 16: 325-334.
17. Maeda S, Sahara N, Saito Y, Murayama S, Ikai A, et al. (2006) Increased levels of granular tau oligomers: an early sign of brain aging and Alzheimer's disease. Neurosci Res 54: 197-201.
18. Berger Z, Roder H, Hanna A, Carlson A, Rangachari V, et al. (2007) Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. J Neurosci 27: 3650-3662.
19. Shin RW, Ogomori K, Kitamoto T, Tateishi J, (1989) Increased tau accumulation in senile plaques as a hallmark in Alzheimer's disease. Am J Pathol 134: 1365-1371.
20. Mitchell TW, Mufson EJ, Schneider JA, Cochran EJ, Nissanov J, et al. (2002) Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease. Ann Neurol 51: 182-189.
21. Kosik KS, Joachim CL, Selkoe DJ, (1986) Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc Natl Acad Sci U S A 83: 4044-4048.
22. Sjogren M, Davidsson P, Tullberg M, Minthon L, Wallin A, et al. (2001) Both total and phosphorylated tau are increased in Alzheimer's disease. J Neurol Neurosurg Psychiatry 70: 624-630.
23. Kitazawa M, Oddo S, Yamasaki TR, Green KN, LaFerla FM, (2005) Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J Neurosci 25: 8843-8853.
24. Lee DC, Rizer J, Selenica ML, Reid P, Kraft C, et al. (2010) LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice. J Neuroinflammation 7: 56.
25. Binder LI, Frankfurter A, Rebhun LI, (1985) The distribution of tau in the mammalian central nervous system. J Cell Biol 101: 1371-1378.
26. Papasozomenos SC, Binder LI, (1987) Phosphorylation determines two distinct species of Tau in the central nervous system. Cell Motil Cytoskeleton 8: 210-226.
27. LoPresti P, Szuchet S, Papasozomenos SC, Zinkowski RP, Binder LI, (1995) Functional implications for the microtubule-associated protein tau: localization in oligodendrocytes. Proc Natl Acad Sci U S A 92: 10369-10373.
28. Odawara T, Iseki E, Kosaka K, Akiyama H, Ikeda K, et al. (1995) Investigation of tau-2 positive microglia-like cells in the subcortical nuclei of human neurodegenerative disorders. Neurosci Lett 192: 145-148.
29. Ghoshal N, Garcia-Sierra F, Fu Y, Beckett LA, Mufson EJ, et al. (2001) Tau-66: evidence for a novel tau conformation in Alzheimer's disease. J Neurochem 77: 1372-1385.
30. Uchihara T, Tsuchiya K, Nakamura A, Ikeda K, (2000) Appearance of tau-2 immunoreactivity in glial cells in human brain with cerebral infarction. Neurosci Lett 286: 99-102.
31. Iseki E, Yamamoto R, Murayama N, Minegishi M, Togo T, et al. (2006) Immunohistochemical investigation of neurofibrillary tangles and their tau isoforms in brains of limbic neurofibrillary tangle dementia. Neurosci Lett 405: 29-33.
32. Yoshida M, (2006) Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies. Neuropathology 26: 457-470.
33. Spittaels K, Van den Haute C, Van Dorpe J, Bruynseels K, Vandezande K, et al. (1999) Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am J Pathol 155: 2153-2165.
34. Li HL, Wang HH, Liu SJ, Deng YQ, Zhang YJ, et al. (2007) Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration. Proc Natl Acad Sci U S A 104: 3591-3596.
35. Liang CC, Park AY, Guan JL, (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2: 329-333.
36. Abbi S, Ueda H, Zheng C, Cooper LA, Zhao J, et al. (2002) Regulation of focal adhesion kinase by a novel protein inhibitor FIP200. Mol Biol Cell 13: 3178-3191.
37. Sloane JA, Hollander W, Moss MB, Rosene DL, Abraham CR, (1999) Increased microglial activation and protein nitration in white matter of the aging monkey. Neurobiol Aging 20: 395-405.
38. Lucin KM, Wyss-Coray T, (2009) Immune activation in brain aging and neurodegeneration: too much or too little? Neuron 64: 110-122.
39. El KJ, Toft M, Hickman SE, Means TK, Terada K, et al. (2007) Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med 13: 432-438.
40. Babcock AA, Kuziel WA, Rivest S, Owens T, (2003) Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J Neurosci 23: 7922-7930.
41. Nimmerjahn A, Kirchhoff F, Helmchen F, (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308: 1314-1318.
42. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, et al. (2005) ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8: 752-758.
43. Streit WJ, Walter SA, Pennell NA, (1999) Reactive microgliosis. Prog Neurobiol 57: 563-581.
44. Soltys Z, Ziaja M, Pawlinski R, Setkowicz Z, Janeczko K, (2001) Morphology of reactive microglia in the injured cerebral cortex. Fractal analysis and complementary quantitative methods. J Neurosci Res 63: 90-97.
45. Bhaskar K, Konerth M, Kokiko-Cochran ON, Cardona A, Ransohoff RM, et al. (2010) Regulation of tau pathology by the microglial fractalkine receptor. Neuron 68: 19-31.
46. Tesseur I, Van Dorpe J, Spittaels K, Van den Haute C, Moechars D, et al. (2000) Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice. Am J Pathol 156: 951-964.
47. Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, et al. (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293: 1487-1491.
48. Sjogren M, Vanderstichele H, Agren H, Zachrisson O, Edsbagge M, et al. (2001) Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. Clin Chem 47: 1776-1781.
49. Hu YY, He SS, Wang X, Duan QH, Grundke-Iqbal I, et al. (2002) Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients: an ultrasensitive bienzyme-substrate-recycle enzyme-linked immunosorbent assay. Am J Pathol 160: 1269-1278.
50. Todaro GJ, Lazar GK, Green H, (1965) The initiation of cell division in a contact-inhibited mammalian cell line. J Cell Physiol 66: 325-333.
51. Napoli I, Neumann H, (2009) Microglial clearance function in health and disease. Neuroscience 158: 1030-1038.
52. Neumann H, Kotter MR, Franklin RJ, (2009) Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 132: 288-295.
53. Smith JA, Das A, Ray SK, Banik NL, (2012) Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull 87: 10-20.
54. Simon D, Garcia-Garcia E, Royo F, Falcon-Perez JM, Avila J, (2012) Proteostasis of tau. Tau overexpression results in its secretion via membrane vesicles. FEBS Lett 586: 47-54.
55. Lee S, Kim W, Li Z, Hall GF, (2012) Accumulation of vesicle-associated human tau in distal dendrites drives degeneration and tau secretion in an in situ cellular tauopathy model. Int J Alzheimers Dis 2012: 172837.
56. Saman S, Kim W, Raya M, Visnick Y, Miro S, et al. (2012) Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. J Biol Chem 287: 3842-3849.
57. Hirokawa N, Funakoshi T, Sato-Harada R, Kanai Y, (1996) Selective stabilization of tau in axons and microtubule-associated protein 2C in cell bodies and dendrites contributes to polarized localization of cytoskeletal proteins in mature neurons. J Cell Biol 132: 667-679.
58. Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, et al. (2010) Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 142: 387-397.
59. Arrasate M, Perez M, Avila J, (2000) Tau dephosphorylation at tau-1 site correlates with its association to cell membrane. Neurochem Res 25: 43-50.
60. Brandt R, Leger J, Lee G, (1995) Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J Cell Biol 131: 1327-1340.
61. Maas T, Eidenmuller J, Brandt R, (2000) Interaction of tau with the neural membrane cortex is regulated by phosphorylation at sites that are modified in paired helical filaments. J Biol Chem 275: 15733-15740.
62. Crespo-Biel N, Canudas AM, Camins A, Pallas M, (2007) Kainate induces AKT, ERK and cdk5/GSK3beta pathway deregulation, phosphorylates tau protein in mouse hippocampus. Neurochem Int 50: 435-442.
63. Song X, Tanaka S, Cox D, Lee SC, (2004) Fcgamma receptor signaling in primary human microglia: differential roles of PI-3K and Ras/ERK MAPK pathways in phagocytosis and chemokine induction. J Leukoc Biol 75: 1147-1155.
64. Farber K, Kettenmann H, (2005) Physiology of microglial cells. Brain Res Brain Res Rev 48: 133-143.
65. Liu SJ, Zhang AH, Li HL, Wang Q, Deng HM, et al. (2003) Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory. J Neurochem 87: 1333-1344.
66. Martin M, Rehani K, Jope RS, Michalek SM, (2005) Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol 6: 777-784.
67. Tak PP, Firestein GS, (2001) NF-kappaB: a key role in inflammatory diseases. J Clin Invest 107: 7-11.
68. Liu F, Grundke-Iqbal I, Iqbal K, Gong CX, (2005) Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur J Neurosci 22: 1942-1950.
69. Zhao WQ, Feng C, Alkon DL, (2003) Impairment of phosphatase 2A contributes to the prolonged MAP kinase phosphorylation in Alzheimer's disease fibroblasts. Neurobiol Dis 14: 458-469.
70. Vogelsberg-Ragaglia V, Schuck T, Trojanowski JQ, Lee VM, (2001) PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus. Exp Neurol 168: 402-412.
71. Hanisch UK, Kettenmann H, (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10: 1387-1394.
72. Stossel TP, (1993) On the crawling of animal cells. Science 260: 1086-1094.
73. Mitchison TJ, Cramer LP, (1996) Actin-based cell motility and cell locomotion. Cell 84: 371-379.
74. Dehmelt L, Halpain S, (2004) Actin and microtubules in neurite initiation: are MAPs the missing link? J Neurobiol 58: 18-33.
75. Perlmutter LS, Barron E, Chui HC, (1990) Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease. Neurosci Lett 119: 32-36.
76. Heneka MT, O'Banion MK, (2007) Inflammatory processes in Alzheimer's disease. J Neuroimmunol 184: 69-91.
77. Yoshiyama Y, Higuchi M, Zhang B, Huang SM, Iwata N, et al. (2007) Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53: 337-351.
78. Simard AR, Soulet D, Gowing G, Julien JP, Rivest S, (2006) Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49: 489-502.
79. Shaftel SS, Kyrkanides S, Olschowka JA, Miller JN, Johnson RE, et al. (2007) Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology. J Clin Invest 117: 1595-1604.
80. Terao A, Apte-Deshpande A, Dousman L, Morairty S, Eynon BP, et al. (2002) Immune response gene expression increases in the aging murine hippocampus. J Neuroimmunol 132: 99-112.
81. Weindruch R, Kayo T, Lee CK, Prolla TA, (2002) Gene expression profiling of aging using DNA microarrays. Mech Ageing Dev 123: 177-193.
82. Cakman I, Rohwer J, Schutz RM, Kirchner H, Rink L, (1996) Dysregulation between TH1 and TH2 T cell subpopulations in the elderly. Mech Ageing Dev 87: 197-209.
83. Pearson VL, Rothwell NJ, Toulmond S, (1999) Excitotoxic brain damage in the rat induces interleukin-1beta protein in microglia and astrocytes: correlation with the progression of cell death. Glia 25: 311-323.
84. Raivich G, Bohatschek M, Kloss CU, Werner A, Jones LL, et al. (1999) Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function. Brain Res Brain Res Rev 30: 77-105.
85. Cheng B, Christakos S, Mattson MP, (1994) Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 12: 139-153.
86. Carlson NG, Wieggel WA, Chen J, Bacchi A, Rogers SW, et al. (1999) Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways. J Immunol 163: 3963-3968.
87. Chung HS, Kim SN, Jeong JH, Bae H (2013) A Novel Synthetic Compound 4-Acetyl-3-methyl-6-(2-bromophenyl)pyrano[3,4-c]pyran-1,8-dione Inhibits the Production of Nitric Oxide and Proinflammatory Cytokines Via the NF-kappaB Pathway in Lipopolysaccharide-Activated Microglia Cells. Neurochem Res.
88. Bashir A, Haq E, (2011) Effect of psychosine on inducible nitric-oxide synthase expression under different culture conditions: implications for Krabbe disease. Eur Rev Med Pharmacol Sci 15: 1282-1287.
89. Frost B, Jacks RL, Diamond MI, (2009) Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 284: 12845-12852.
90. Buerger K, Ewers M, Pirttila T, Zinkowski R, Alafuzoff I, et al. (2006) CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease. Brain 129: 3035-3041.
91. Tapiola T, Overmyer M, Lehtovirta M, Helisalmi S, Ramberg J, et al. (1997) The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease. Neuroreport 8: 3961-3963.